Browse by category

Positive Phase 1 data shows potential of CK-0045 to improve cardiometabolic risk factors

Cytoki Pharma has revealed positive data from a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of CK-0045, its...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

1 hour ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

2 hours ago

Racial and ethnic groups face barriers to obtaining OMMs

3 hours ago

Weekly Digest